A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-12
DOI
10.1038/s41467-022-34633-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
- (2022) Wilfredo F. Garcia-Beltran et al. CELL
- Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
- (2022) Constanze Kuhlmann et al. LANCET
- Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants
- (2022) Kang Wang et al. NATURE
- Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
- (2022) Yunlong Cao et al. NATURE
- Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera
- (2022) Alexander Muik et al. SCIENCE
- Cryo-EM structure of the SARS-CoV-2 Omicron spike
- (2022) Gabriele Cerutti et al. Cell Reports
- Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine
- (2022) Yihao Liu et al. Cell Discovery
- Protection by a Fourth Dose of BNT162b2 against Omicron in Israel
- (2022) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
- (2022) Jingyou Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike
- (2022) Victoria Stalls et al. Cell Reports
- Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets
- (2021) Haley L. Dugan et al. IMMUNITY
- Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike
- (2021) Pei Tong et al. CELL
- Time of day influences immune response to an inactivated vaccine against SARS-CoV-2
- (2021) Hui Zhang et al. CELL RESEARCH
- Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2
- (2021) Matthias Tenbusch et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
- (2021) Ann R. Falsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner
- (2021) Roanne Keeton et al. Cell Host & Microbe
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
- (2020) Yanchun Peng et al. NATURE IMMUNOLOGY
- Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans
- (2019) Surender Khurana et al. Nature Communications
- Epitope-Specific Suppression of IgG Responses by Passively Administered Specific IgG: Evidence of Epitope Masking
- (2017) Joakim J. E. Bergström et al. Frontiers in Immunology
- B-cell exhaustion in HIV infection
- (2014) Susan Moir et al. Current Opinion in HIV and AIDS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now